Cefdinir Capsule
Product Images NDC 67877-543

2 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 67877-543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefdinir-structure (Cefdinir Structure)

Cefdinir-structure (Cefdinir Structure)
Chemical structure diagram of the active ingredient cefdinir, showing its molecular framework with atoms and bonds clearly represented.*
FDA Label Image

Cefdinir-300mg-60capsules (Cefdinir 300mg 60capsules)

Cefdinir-300mg-60capsules (Cefdinir 300mg 60capsules)
Label for Cefdinir Capsules, USP, 300 mg strength. The label states the product is for oral use and prescription only, containing 60 capsules. It includes storage instructions and a warning to keep out of reach of children. Manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Bedminster, NJ. The NDC number 67877-543 is shown with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.